Medical/Pharmaceuticals
Guardant Health launches Shield blood-based screening test for colorectal cancer in South Korea
SINGAPORE, Nov. 13, 2023 /PRNewswire/ -- Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, announced that it has launched its blood-based colorectal cancer screening test, ShieldTM, in collaboration with Samsung Medical Center inSouth Korea. Colorectal cancer (CRC) is o...
2023-11-13 08:00
2288
First Patient Dosed in Phase III ProstACT GLOBAL Study of Antibody-based Prostate Cancer Therapy Candidate, TLX591
MELBOURNE, Australia, Nov. 13, 2023 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that the first patient has been dosed in the Company's Phase III ProstACT GLOBAL study of its investigational prostate-specific membrane antigen (PSMA) targeting radio...
2023-11-13 07:38
1210
Gillette & Braun sign Major Partnership with Movember
SYDNEY, Nov. 13, 2023 /PRNewswire/ -- In Australia, one in five men will be diagnosed with prostate cancer in their lifetime. One man globally dies by suicide every minute. Testicular cancer is the most common cancer among younger men. This November, Procter & Gamble's leading grooming brands Gi...
2023-11-13 05:30
1834
Fapon Inaugurates State-of-the-Art R&D Center in Lexington, MA
LEXINGTON, Mass., Nov. 11, 2023 /PRNewswire/ -- Fapon, a global leading life sciences organization, is thrilled to announce the grand opening of its US-based Research and Development (R&D) Center, strategically located in Lexington, Massachusetts. This Center represents Fapon's unwavering commitme...
2023-11-11 20:36
2679
SeekIn Presents Retrospective and Prospective Validation Studies of SeekInCare Multi-omics Multi-cancer Early Detection test at the 20th ICGC Workshop and 7th ARGO Meeting in New York
One Retrospective Cohort, One Prospective Cohort, in Total of ~2,400 Cancer Patients and Non-cancer Individuals Demonstrate the Performance of SeekInCare Test to Detect Multiple Cancer Types and Predict Tissue of Origin of Cancers The Achievement of 65.5% Sensitivity at 97.9% Specificity in the ...
2023-11-10 21:00
1800
Seegene Earns Improved ESG Rating from the Korea Institute of Corporate Governance and Sustainability
Company attributes B+ rating to progress related to its Human Rights Management Declaration, eco-friendly shipping box and the establishment of an internal ESG Committee SEOUL, South Korea, Nov. 10, 2023 /PRNewswire/ -- Seegene Inc. (KQ096530), a leading South Korean company providing a total so...
2023-11-10 20:00
3430
Shaping Global Policy: IFPA's Psoriatic Disease Response Index in the Western Pacific
STOCKHOLM, Nov. 10, 2023 /PRNewswire/ -- Psoriatic disease, recognized as a serious noncommunicable disease by the World Health Organization (WHO), impacts millions worldwide. A pioneering advocacy tool, the Psoriatic Disease Response Index, has emerged to facilitate a vital policy discussion, dr...
2023-11-10 19:18
3474
Lecheng, MSD vow to deepen medical cooperation
BEIJING, Nov. 10, 2023 /PRNewswire/ -- A news report from chinadaily.com.cn:
2023-11-10 18:03
2229
H2U Secures Strategic Investment from InnoTherapy as Recognition from Seoul Clinical Laboratories (SCL)
H2U platform enters the South Korean healthcare sector, driving AI-powered data analytics to expand their digital health offerings TAIPEI, Nov. 10, 2023 /PRNewswire/ -- H2U, Taiwan's premier digital health brand, proudly announced another successful round of funding this year after receiving rec...
2023-11-10 17:48
2342
FEBICO actively seeking business partners in United States, introduces "High- Spermidine" chlorella health supplements to satisfy U.S. market
TAIPEI, Nov. 10, 2023 /PRNewswire/ -- FEBICO
2023-11-10 17:08
1091
TCT 2023: The Efficacy and Safety of the SMART Trial Presented by World Renowned Expert
SAN FRANCISCO, Nov. 10, 2023 /PRNewswire/ -- On October 26, 2023, SyMap Medical invited ProfessorFelix Mahfoud, Vice-Chair of the Working Group Interventional Hypertension Treatment of the European Society of Hypertension (ESH) and a distinguished authority in the renal denervation (RDN) field, t...
2023-11-10 16:46
1187
GC Genome Enters License Agreement with MP Group
- Collaboration includes the transfer of GC Genome's essential wet lab know-how for SNP genotyping service. YONGIN, South Korea, Nov. 10, 2023 /PRNewswire/ -- GC Genome Corporation, a leading diagnostics company, today announced that it has entered into a collaboration and exclusive license agre...
2023-11-10 13:00
1547
MVR-T3011 IV, Global First Intravenous Oncolytic Product, Successfully Concludes Phase I Clinical Study in the U.S. with Outstanding Safety Results
SHENZHEN, China, Nov. 9, 2023 /PRNewswire/ -- On November 9, 2023, ImmVira announced the successful completion of Phase I clinical study conducted on late-stage patients with various tumor types for our intravenous oncolytic product, MVR-T3011 IV, inthe United States. This milestone was marked by...
2023-11-10 08:00
1597
PharmAbcine Receives Safety Review Committee Approval to Advance to Dose Level 2 of Clinical Trial of PMC-403 with Neovascular Age-related Macular Degeneration following Dose Level 1 Safety Data
* Safety Review Committee evaluated dose level 1 safety data of PMC-403 and approved advancing to the higher dose treatment. * The starting dose (0.7mg) of PMC-403 showed potential in improving eyesight for neovascular age-related macular degeneration patients with suboptimal response to cur...
2023-11-09 21:00
1172
TREEFROG THERAPEUTICS REINFORCES EXECUTIVE COMMITTEE WITH THREE NEW MEMBERS
Jaime Arango, Chief Financial Officer, Jens Schröder as Chief Medical Officer
andRachel Mooney, Chief Communications Officer
BORDEAUX, France, Nov. 9, 2023 /PRNewswire/ -- TreeFrog Therapeutics
2023-11-09 19:01
2920
Eccogene Enters Exclusive License Agreement With AstraZeneca to Develop and Commercialize Small Molecule GLP-1 Receptor Agonist ECC5004 for Cardiometabolic Diseases
Eccogene will receive initial upfront payment of $185 million. Eccogene is also eligible to receive up to$1.825 billion in future clinical, regulatory, and commercial milestones, as well as royalty payments. AstraZeneca will receive an exclusive license to develop and commercialize ECC5004 in al...
2023-11-09 15:05
1110
Noah Launches "Play The Full Game" Campaign with Singaporean Football Legend Fandi Ahmad as Brand Ambassador
SINGAPORE, Nov. 9, 2023 /PRNewswire/ -- Noah, the telehealth platform tailored for men and created by Ordinary Folk, is pleased to announce the launch of its "Play The Full Game" campaign and the appointment ofFandi Ahmad as Noah's brand ambassador. The campaign aims to empower men to have the co...
2023-11-09 14:31
1822
West Pharmaceutical Services Appoints Nilesh Shah as Vice President and General Manager of Emerging Markets
SINGAPORE, Nov. 9, 2023 /PRNewswire/ -- West Pharmaceutical Services, Inc.
2023-11-09 12:58
9002
European Wellness and DXN Sign MoU to Establish World-Class Wellness Centre!
CYBERJAYA, Malaysia, Nov. 9, 2023 /PRNewswire/ -- European Wellness Biomedical Group (EW Group) has signed a Memorandum of Understanding with DXN Holdings Berhad (DXN) to jointly develop and establish a comprehensive wellness centre that draws from the extensive expertise and experience of both p...
2023-11-09 11:46
2172
DiscGenics Announces Research Collaboration with the U.S. Department of Veterans Affairs for Tissue-Engineered Discs with Discogenic Cells
Feasibility Project Awarded VA Technology Transfer Program BRAVE Funding SALT LAKE CITY, Nov. 9, 2023 /PRNewswire/ -- DiscGenics, Inc., a privately held, late-stage clinical, biopharmaceutical company focused on developing regenerative cell-based therapies that alleviate pain and restore function...
2023-11-09 08:15
1656
Week's Top Stories
Most Reposted
Earth Day 2024: Angel Yeast Continues to Tackle Plastic Pollution Challenges With Bio-based Material Solutions
[Picked up by 294 media titles]
2024-04-22 16:00
Trina Solar and PetroGreen Partner to Accelerate Philippine Solar Adoption with 117MW Supply Agreement
[Picked up by 291 media titles]
2024-04-22 06:00
Revenue Surpasses 50 Billion: BlueFocus Accelerates Towards the AI Native Era
[Picked up by 275 media titles]
2024-04-23 15:43
INTAMSYS Becomes 3D Printing Equipment Supplier for the WORLDSKILLS LYON 2024 COMPETITION
[Picked up by 273 media titles]
2024-04-24 17:09
Introducing Wacom Movink: The first OLED pen display, and the thinnest and lightest Wacom pen display ever
[Picked up by 268 media titles]
2024-04-24 13:00
Most Read
Automation Anywhere Appoints Tim McDonough as Chief Marketing Officer to Drive Global Awareness and Growth for the Leader in AI-Powered Automation
2024-04-24 03:57
6686
Earth Day 2024: Angel Yeast Continues to Tackle Plastic Pollution Challenges With Bio-based Material Solutions
2024-04-22 16:00
4462
Trina Solar and PetroGreen Partner to Accelerate Philippine Solar Adoption with 117MW Supply Agreement
2024-04-22 06:00
4057
INTAMSYS Becomes 3D Printing Equipment Supplier for the WORLDSKILLS LYON 2024 COMPETITION
2024-04-24 17:09
3812
Revenue Surpasses 50 Billion: BlueFocus Accelerates Towards the AI Native Era
2024-04-23 15:43
3700